Pharma Patent Lifecycles

PRE-CONFERENCE WORKSHOP • 20th June 2011 • 13:00 - 16:30

Constructing Patent Settlement Agreements and Devising Effective SPC Strategies

This workshop will provide you with in-depth guidance on drafting patent settlement agreements and adopting effective strategies to successfully protect and extend your patent terms. The workshop leaders will also walk you through the practical requirements for drafting and fi ling SPC extension applications in light of recent regulatory and case law developments across the US and Europe. This workshop will equip you with the key practical and strategic tools you need to gain effective patent lifecycle extensions in today’s challenging pharma industry.

12:30 Coffee and Registration

13:00 Constructing Patent Settlement Agreements

Workshop Moderators:
Axel Schulz
Partner, White & Case (Belgium)

Jürgen Dressel
Head Patent Litigations (ex USA)
Novartis Pharma AG (Switzerland)

• Analysing the current EU approach to patent settlement agreements
• The US approach to patent settlement agreements
• Strategies for constructing different types of patent settlement agreements
• Factors to take into account when deciding whether to settle a case
• Anti-trust assessment of the various strategies for constructing patent settlement agreements

14:30 Refreshment Break

15:00 Devising Effective SPC Strategies

Workshop Moderators:
Andrew Sharples
Partner, EIP (UK)

Daniel Wise
Senior Associate, Carpmaels & Ransford (UK)

Edward Oates
Senior Associate, Carpmaels & Ransford (UK)

• Which patent should you choose?
• How should you define the product?
• Which marketing authorisation
• When should you file?
• Other factors to consider
• Avoiding the pitfalls when seeking multiple and follow-on SPCs
• Assessing the extent of obtaining SPCs for medical devices
• How to strategically amend your patents to improve your SPC position
• Taking paediatric extensions into account

16:30 End of Pre-Conference Workshop

- Actions -

- Share -